Primary CNS lymphoma is a rare cancer that arises from malignant white blood cells. Affected individuals develop tumors in ...

Researchers report encouraging early results from a first-in-human clinical trial led by Children's National using a new ...

CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today ...

The brain and spinal cord are the central pillars of the human central nervous system (CNS), orchestrating everything from movement to sensation. Despite significant advances in neuroscience, our ...

- CANDID-CNS TM achieves an 83% success rate for predicting small molecule brain penetration and distribution versus a 64% success rate for the industry standard CNS-MPO score - Only ~2% of small ...

Inflammatory pathways involving microglia, astrocytes, and cytokine signaling are widely implicated in disorders including Alzheimer’s disease, Parkinson’s disease, ALS, multiple sclerosis, and ...

HOUSTON, TX / ACCESSWIRE / November 25, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

TTUHSC’s Quentin R. Smith, Ph.D., and a team of researchers investigated methods to accurately measure drug permeability across the blood-brain barrier. For decades, scientists across the globe have ...